Johnson & Johnson Talc Baby Powder Removed From Market Amid Thousands of Cancer Claims

As thousands of talcum powder lawsuits move closer to trial in the U.S., each involving claims that Johnsons’ Baby Powder caused women to develop ovarian cancer or other injuries, Johnson & Johnson has announced it is removing all talc-based Baby Powder products from the market in North America.

In a press release issued on May 19, the manufacturer indicated it will no longer sell Johnson’s Baby Powder products made with talc in the United States or Canada. However, it will continue to sell Baby Powder products made using cornstarch, which have not been implicated in lawsuits over a cancer risk.

Johnson’s Baby Powder first hit the market in 1894 and was a symbol of the company for more than 100 years. However, current sales have dropped to only 0.5% of Johnson & Johnson’s U.S. Consumer Health department’s business, and the company has faces nearly 20,000 Baby Powder lawsuits¬†brought by women who indicate they developed ovarian cancer, mesothelioma or other injuries after regularly applying the talc-based powder for feminine hygiene.

Learn More About

Talcum Powder Lawsuits

Talcum powder or talc powder may cause women to develop ovarian cancer.

Learn More About this Lawsuit See If You Qualify For Compensation

Plaintiffs allege Johnson & Johnson knew for decades about the potential link between talcum powder and cancer, yet withheld information and warnings from consumers and continued to promote the products for use by adult women.

While the company suggests it will continue to fight the litigation after removing talc Baby Powder from the market, the move raises speculation that Johnson & Johnson may soon consider negotiating settlements, following a series of legal setbacks.

Johnson & Johnson has already been hit with several multi-million dollar verdicts in state court trials, and has rested most of its legal defense strategy on excluding plaintiffs’ expert witness testimony under the federal Daubert standard. However, last month the U.S. District Judge presiding over the litigation rejected this argument and cleared the way for the talc lawsuits to proceed in the federal court system.

Earlier this week, Imerys Talc, which has been a co-defendant in the litigation for its role in supplying the raw talc used in Johnson & Johnson products, announced it has agreed to auction off subsidiaries and talc mines in the U.S. and Canada to fund a settlement with talc plaintiffs, which will resolve its liability and allow the company to emerge from bankruptcy.

In the statement issued late Tuesday, Johnson & Johnson continued to maintain that it is “steadfastly confident in the safety of talc-based Johnson’s Baby Powder”, and indicates that it plans to continue “vigorously defending the product” in the courtroom.

Following the recent failure to exclude plaintiffs’ expert witnesses from testifying at trial, it is widely expected that the judge presiding over the litigation will fast-track a small group of “bellwether” cases for trial, to help the parties gauge how juries may respond to certain evidence and testimony that may be repeated throughout the litigation.

After any bellwether trials, if Johnson & Johnson is unable to reach talcum powder settlements or another resolution for the claims, each individual lawsuits may ultimately be remanded back to U.S. District Courts nationwide for thousands of separate trials nationwide in the coming years.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.